Keywords
Assessment
Diagnosis
Examination
Treatment
Submitted : 2025-07-08
Accepted : 2025-07-23
Published : 2025-08-07
Abstract
As a severe neurological disease, cerebral hemorrhage is dangerous and progresses rapidly, with high disability and fatality rates. Its occurrence seriously harms patients’ lives and health, and also causes a heavy social burden. Timely diagnosis and treatment of cerebral hemorrhage are essential for improving patients’ prognosis. This article reviews the research progress in emergency treatment for patients with cerebral hemorrhage, providing a basis for diagnosis and treatment.
References
Arndt P, Chahem C, Luchtmann M, et al., 2024, Risk Factors for Intracerebral Hemorrhage in Small-Vessel Disease and Non-Small-Vessel Disease Etiologies—An Observational Proof-of-Concept Study. Front Neurol, 15: 1322442.
Xu L, Wang Z, Wu W, et al., 2024, Global, Regional, and National Burden of Intracerebral Hemorrhage and Its Attributable Risk Factors from 1990 to 2021: Results from the 2021 Global Burden of Disease Study. BMC Public Health, 24(1): 2426.
Larsson S, Chen J, Gill D, et al., 2024, Risk Factors for Intracerebral Hemorrhage: Genome-Wide Association Study and Mendelian Randomization Analyses. Stroke, 55(6): 1582–1591.
Tan L, Wang C, 2024, Correlation Analysis between Serum Galectin-9 and PD-L1 Protein Levels and Severity and Prognosis of Hypertensive Cerebral Hemorrhage Patients. Anhui Medical and Pharmaceutical Journal, 28(10): 2069–2072.
Liu C, Xie K, Xu F, et al., 2023, The Effect of Early Intensive Blood Pressure Lowering on the Prognosis of Patients with Hypertensive Cerebral Hemorrhage. Chinese Journal of Clinical Research, 36(3): 339–342.
Wang Y, Qin Y, Guo C, et al., 2024, A Prospective Study on the Relationship between Early Blood Pressure Management and Prognosis of Patients with Acute Hypertensive Cerebral Hemorrhage. Chinese Journal of Emergency Resuscitation and Disaster Medicine, 19(2): 183–186.
Baharoglu M, Cordonnier C, Salman R, et al., 2016, Platelet Transfusion versus Standard Care after Acute Stroke Due to Spontaneous Cerebral Haemorrhage Associated with Antiplatelet Therapy (PATCH): A Randomised, Open-Label, Phase 3 Trial. Lancet, 387(10038): 2605–2613.
Li H, 2023, Tranexamic Acid for the Treatment of Non-Vitamin K Antagonist Oral Anticoagulant-Associated Intracerebral Hemorrhage. International Journal of Cerebrovascular Diseases, 31(9): 657.
Babi M, James M, 2017, Peri-Hemorrhagic Edema and Secondary Hematoma Expansion after Intracerebral Hemorrhage: From Benchwork to Practical Aspects. Front Neurol, 8: 4.
Zhou X, Liu C, Zhang H, 2024, Evaluation of the Effect of Hemostatic Agents in Patients with Hypertensive Cerebral Hemorrhage Based on CYP2C19 Gene Methylation Level and Thrombelastography Parameters. Hebei Medical Journal, 46(7): 997–1001.